One of the most egregious outcomes of marijuana prohibition is that many sick people cannot legally access the medicine that works best for them. The Drug Policy Alliance (DPA) is committed to legalizing marijuana at the state and federal levels and improving medical marijuana programs to better protect patients’ rights and access to medicine.
Current Medical Marijuana Laws in the U.S.
Three states will consider initiatives that allow access to cannabis for those with qualifying medical conditions and establish state regulatory systems for the cultivation and distribution of cannabis to qualified patients. Read more about the initiatives:
The CARERS Act is the first-ever bill in the U.S. Senate to let states legalize marijuana for medical use. Tell your Senators to legalize medical marijuana nationwide!
Why Should We Legalize?
Provide effective medicine
For many seriously ill people, medical marijuana is the only medicine that relieves their pain and suffering, or treats symptoms of their medical condition, without debilitating side effects.
Marijuana has been shown to alleviate symptoms of a huge variety of serious medical conditions including cancer, AIDS, and glaucoma, and is often an effective alternative to synthetic painkillers.
Marijuana prohibition has thwarted research within the United States to uncover the best and most effective uses for marijuana as a medicine. Legalization would allow research into marijuana’s medical benefits to move forward.
10 Facts about Marijuana
Why Are CBD-Focused Laws Not Enough?
The DEA: Four Decades of Impeding and Rejecting Science
Spending Bill Allows Legalization of Marijuana Possession in Washington, D.C. to Move Forward, but Prevents Taxing and Regulating Marijuana like Alcohol
Momentum Builds Nationally to End the Failed War on Drugs
WASHINGTON, D.C. - The final “cromnibus” federal spending bill that Congress passed over the weekend contains historic language prohibiting the U.S. Justice Department from spending any money to undermine state medical marijuana laws.
Family’s Pleas for Relief for Little Donella Nocera Went Unheeded
Families, Advocates Call Upon Governor Cuomo to Immediately Help Suffering New Yorkers
NEW YORK: Yesterday, 8 year old Donella Nocera of Niagra Falls passed away while waiting for emergency access to medical marijuana to ease her end-of-life suffering.
Top Congressional Leaders Side with States on Hemp Research and Medical Marijuana
Provisions on D.C. Marijuana Legalization Remain Unclear: Advocates Say Any Congressional Interference with Law that Passed with 70% Support is Outrageous
The final “must pass” federal spending bill that Congress will consider this week, also known as the “cromnibus,”and released by senior appropriators last night includes an amendment that prohibits the U.S. Justice Department from spending any money to undermine state medical marijuana laws. The spending bill also includes a bipartisan amendment that prohibits the DEA from blocking implementation of a federal law passed last year by Congress that allows hemp cultivation for academic and agricultural research purposes in states that allow it.
Marijuana’s medical efficacy derives largely from more than 70 unique chemicals – called cannabinoids – that each have important therapeutic properties. Currently, 23 states, the District of Columbia, Guam and Puerto Rico have adopted comprehensive medical marijuana laws that provide patients with access to all of marijuana’s beneficial ingredients.
Loses Despite Clear Majority Support, Thanks to Unique Florida Law Requiring 60% for Ballot Initiatives and $5 Million Opposition Campaign
National Implications: Majority Support Sends Strong Message, Regardless of 60% Florida Requirement
Today, a large majority of voters in Florida approved Amendment 2, a ballot initiative that makes Florida, with its huge population and bellwether status in American politics, the very first state in the South to see a majority vote in favor of a medical marijuana law.
Move May Force Producers to Move to a Cash-only Payment System
Santa Fe, NM - Eight months after the Federal Justice Department and Treasury Department announced new guidelines allowing banks to work with marijuana businesses, some of the credit unions in New Mexico sent letters to close to half of the State’s licensed medical marijuana producers saying they will no longer accept their business and proceeded with closing their accounts. The credit unions assert that they are unable to comply with federal guidelines for servicing the accounts. This move leaves producers in the lurch, with either having to operate on a cash only basis o
Patients, Families, and Advocates Thank Cuomo For Federal Request, But Urge Additional State Action to Save Lives of Critically Ill Patients
Patients Call on Governor to Create State-Based Emergency Access Program
New York — Friday, the Cuomo Administration sent a letter to Deputy Attorney General Cole following up on an earlier letter to U.S. Attorney General Holder sent on August 13, 2014. Both letters asked the Department of Justice (DOJ) to extend a narrow, time-limited exception to federal law to allow the importation of certain strains of medical marijuana from other states for use by children in New York with severe forms of epilepsy.
Global Commission on Drug Policy
This report reflects a new evolution in the thinking of the Global Commission, which includes Kofi Annan, Richard Branson, and the former presidents of Brazil, Chile, Colombia, Mexico, Poland, Portugal and Switzerland. They not only reiterate their demands for decriminalization, alternatives to incarceration, and greater emphasis on public health approaches – but now also call for responsible legal regulation of currently-illegal drugs.
NM Secretary of Health Denies Medical Cannabis Advisory Board’s Recommendation to Add Alzheimer’s Disease and Neurodegenerative Dementia to the List of Qualifying Conditions
SANTA FE—Yesterday the Secretary of Health denied a petition to add Alzheimer’s disease to the list of medical conditions eligible for the medical cannabis program, even though the New Mexico Medical Cannabis Advisory Board voted unanimously to recommend making neurodegenerative dementia, including Alzheimer’s disease, qualifying conditions.
Department of Health Continues to Obstruct MAB’s Statutory Role to Advise the Program; Program Staff Refuse to Answer Any Questions Posed by the Board About the Evidence Supporting Recommended Rule Changes
SANTA FE, NM – Today, the New Mexico Medical Cannabis Advisory Board held a special hearing on proposed rule changes governing the state’s medical cannabis program. The board, frustrated that they were never formally consulted with by the Department of Health prior to releasing proposed rule changes, scheduled the hearing to listen to patients, licensed providers, advocates and the Department staff to inform their recommendations on the rules to the Department.